Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net loss $ (1,000) $ (595,442)
Adjustments to reconcile net loss to net cash used in operating activities:    
Transaction costs allocated to warrant liabilities 155,037
Net gain on investments held in Trust Account (5,428)
Change in fair value of warrant liabilities (1,077,750)
Change in fair value of over-allotment option liability 225,000
Changes in operating assets and liabilities:    
Prepaid expenses (73,865)
Accounts payable 153,601
Accrued expenses 1,000 28,500
Accrued expenses - related party 53,333
Franchise tax payable 97,200
Net cash used in operating activities (1,039,814)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (174,225,000)
Net cash used in investing activities (174,225,000)
Cash Flows from Financing Activities:    
Proceeds from promissory note - related party 188,302
Repayment of promissory note - related party (188,302)
Payment to related party for cancellation of Founder Shares (16,667)
Proceeds from initial public offering, net of underwriter’s discount paid 169,050,000
Proceeds from sale of private placement warrants 7,175,000
Payment of offering costs (466,281)
Proceeds from sale of Founder Shares 25,000 16,667
Net cash provided by financing activities 25,000 175,758,719
Net change in cash 25,000 493,905
Cash - beginning of period 25,000
Cash - end of period $ 25,000 $ 518,905